Coronal synostosis, syndactyly and jejunal atresia
diseaseOn this page
Also known as asymmetrical coronal synostosis, cutaneous syndactyly of the fingers and toes, and jejunal atresia
Summary
Coronal synostosis, syndactyly and jejunal atresia (MONDO:0043083) is a disease. A subtype of synostosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | coronal synostosis, syndactyly and jejunal atresia |
| Mondo ID | MONDO:0043083 |
| MeSH | C536445 |
| UMLS | C2931194 |
| MedGen | 419740 |
| GARD | 0001532 |
| Is cancer (heuristic) | no |
Also known as: asymmetrical coronal synostosis, cutaneous syndactyly of the fingers and toes, and jejunal atresia
Disease family
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › bone disorder › bone development disease › dysostosis › synostosis › coronal synostosis, syndactyly and jejunal atresia
Related subtypes (10): Banki syndrome, humeroradial synostosis, calcaneonavicular coalition, craniosynostosis, tibio-fibular synostosis, multiple synostoses syndrome, humero-radio-ulnar synostosis, congenital radioulnar synostosis, humero-ulnar synostosis, non-syndromic pansynostosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.